This conference will focus on the most recent studies that have uncovered novel molecular pathways involved in response anticancer therapy. A panel of speakers involved in cutting-edge studies on the biological and cellular bases for therapeutic response in cancer will share their vision on how these disruptive discoveries could be exploited to rethink cancer therapies to ultimately improve therapeutics.
Topics: cellular basis, cancer response, patient response, cell line, chemotherapy, hormone therapy, in vivo models, in vivo validated cellular effects, mechanism-based combinations, novel molecular pathways, anticancer therapy, biological basis for therapeutic response, mitochondrial homeostasis, chemotherapy agents, tumor microenvironment, experimental therapeutics, drug repositioning, cancer research, oncology